Please use this identifier to cite or link to this item: http://hdl.handle.net/1843/57778
Type: Artigo de Periódico
Title: 2018 in review: gynecologic cancer insights
Authors: Eduardo Paulino
Angélica Nogueira Rodrigues
Aknar F. C. Calabrich
Andrea P. G. Guimarães
Andreia C. Melo
Daniela Freitas
Fernando C. Maluf
Lilian D. Faroni
Marcelo A. Vieira
Reitan Ribeiro
Abstract: Gynecologic cancers constitute an important burden of disease around the world. Estimates from GLOBOCAN 2018 reveals approximately 1,247,300 incident casesand 596,000 related deaths of cancers of the uterine cervix, corpus uteri, and ovarian, annually around the world. In 2018 lots of promising results to improve disease control have been presented at international gynecological cancer meetings. The current review highlights some of the top gynecologic cancer news of 2018, including the new standard of care for BRCAmutant ovarian cancer patients with maintenance olaparib in first line, benefit of bevacizumab rechallenge for relapsed ovarian cancer patients, and the unexpected results of worse overall survival with minimally invasive surgery in early cervical cancer, among others.
Subject: Bevacizumab
Saúde da mulher
Neoplasias dos Genitais Femininos
language: eng
metadata.dc.publisher.country: Brasil
Publisher: Universidade Federal de Minas Gerais
Publisher Initials: UFMG
metadata.dc.publisher.department: MED - DEPARTAMENTO DE CLÍNICA MÉDICA
Rights: Acesso Aberto
metadata.dc.identifier.doi: 10.5935/1806-6054.20190008
URI: http://hdl.handle.net/1843/57778
Issue Date: 26-Dec-2018
metadata.dc.url.externa: http://www.brazilianjournalofoncology.com.br/details/55/en-US/2018-in-review--gynecologic-cancer-insights
metadata.dc.relation.ispartof: Brazilian Journal Of Oncology
Appears in Collections:Artigo de Periódico

Files in This Item:
File Description SizeFormat 
2018 in review gynecologic cancer insights pdfa.pdf105.11 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.